BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 23158844)

  • 1. Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients.
    Liu YZ; Hou FQ; Ding P; Ren YY; Li SH; Wang GQ
    Virol J; 2012 Nov; 9():274. PubMed ID: 23158844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B.
    Chen J; Wang Y; Wu XJ; Li J; Hou FQ; Wang GQ
    World J Gastroenterol; 2010 Dec; 16(48):6145-50. PubMed ID: 21182232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic analysis of CD127 expression on memory CD8 T cells from patients with chronic hepatitis B during telbivudine treatment.
    Lv G; Ying L; Ma WJ; Jin X; Zheng L; Li L; Yang Y
    Virol J; 2010 Aug; 7():207. PubMed ID: 20807412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro.
    Chen M; Hu P; Ling N; Peng H; Lei Y; Hu H; Zhang D; Ren H
    PLoS One; 2015; 10(3):e0120086. PubMed ID: 25774808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis.
    Penna A; Laccabue D; Libri I; Giuberti T; Schivazappa S; Alfieri A; Mori C; Canetti D; Lampertico P; Viganò M; Colombo M; Loggi E; Missale G; Ferrari C
    J Hepatol; 2012 Jun; 56(6):1239-46. PubMed ID: 22326467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
    Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
    Sprinzl MF; Russo C; Kittner J; Allgayer S; Grambihler A; Bartsch B; Weinmann A; Galle PR; Schuchmann M; Protzer U; Bauer T
    J Viral Hepat; 2014; 21(9):633-41. PubMed ID: 24251783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
    Ma L; Cai YJ; Yu L; Feng JY; Wang J; Li C; Niu JQ; Jiang YF
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1304-11. PubMed ID: 23274669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insufficient immunity led to virologic breakthrough in NAs-treated chronic hepatitis B patients switching to Peg-IFN-ɑ.
    Huang D; Yan W; Han M; Yuan W; Wang P; Chen Y; Wan X; Luo X; Wu D; Ning Q
    Antiviral Res; 2022 Jan; 197():105220. PubMed ID: 34848218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reduction in CD8
    Liu R; Chen Y; Guo J; Li M; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Zhang H; Xie Y
    BMC Infect Dis; 2020 Aug; 20(1):590. PubMed ID: 32778058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8
    Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
    Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
    Yeh ML; Peng CY; Dai CY; Lai HC; Huang CF; Hsieh MY; Huang JF; Chen SC; Lin ZY; Yu ML; Chuang WL
    PLoS One; 2015; 10(4):e0122259. PubMed ID: 25835020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.
    Visvanathan K; Lang T; Ryan K; Wilson R; Skinner NA; Thompson AJ; Ahn SH; Weilert F; Abbott W; Gane E; Colledge D; Li K; Locarnini S; Mansell A; Revill PA
    J Viral Hepat; 2016 Mar; 23(3):170-9. PubMed ID: 26436722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of tenofovir disoproxil fumarate antiviral therapy on virus-specific CD8+T Cells function in patients with chronic hepatitis B].
    Duan SP; Zhu LH; Hou LJ; Wang HW; Zhu XW; Hao J
    Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):421-426. PubMed ID: 34107578
    [No Abstract]   [Full Text] [Related]  

  • 17. Upregulation of NKG2C+ natural killer cells, TLR-2 expression on monocytes and downregulation of regulatory T-cells influence PEG-IFN treatment efficacy in entecavir-suppressed patients with CHB.
    Yan W; Wu D; Wang X; Chen T; Lai Q; Zheng Q; Jiang J; Hou J; Han M; Ning Q
    Antivir Ther; 2015; 20(6):591-602. PubMed ID: 25814467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y; Li X; Ye B; Yang X; Wu W; Chen B; Pan X; Cao H; Li L
    Antiviral Res; 2011 Jul; 91(1):23-31. PubMed ID: 21549152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8
    Xun Z; Lin J; Yu Q; Liu C; Huang J; Shang H; Guo J; Ye Y; Wu W; Zeng Y; Wu S; Xu S; Chen T; Chen J; Ou Q
    Cell Mol Immunol; 2021 Feb; 18(2):461-471. PubMed ID: 33432062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
    Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
    Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.